The proposed sensor may also be extended to a multi-analyte format for the simultaneous detection of CA15-3 and other breast cancer biomarkers, such as CEA and HER2, which is expected to further enhance its clinical applicability. This evidence concerns the gene ERBB2 and breast cancer.